Registry for Eosinophilic Gastrointestinal Disorders
Eosinophilic Gastrointestinal Disorders Registry
Ann & Robert H Lurie Children's Hospital of Chicago · NCT05199532
This study is collecting information from people with Eosinophilic Gastrointestinal Disorders to better understand their symptoms and improve treatments for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 1 Year to 25 Years |
| Sex | All |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05199532 on ClinicalTrials.gov |
What this trial studies
This registry aims to gather comprehensive data on patients with Eosinophilic Gastrointestinal Disorders (EGIDs) to better understand their symptoms, quality of life, and disease progression. By collecting clinical, endoscopic, and histologic data, the study seeks to characterize the clinical phenotype of EGIDs and explore the relationship between disease mechanisms and treatment responses. Additionally, a biorepository will be established to store samples for future research on EGIDs. The ultimate goal is to inform more precise treatment strategies for patients with these conditions.
Who should consider this trial
Good fit: Ideal candidates include patients with a confirmed diagnosis of an EGID or those suspected of having one and undergoing evaluation.
Not a fit: Patients who do not consent to participate in the registry will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and treatment options for patients with Eosinophilic Gastrointestinal Disorders.
How similar studies have performed: Other studies focusing on patient registries for chronic conditions have shown success in improving understanding and treatment outcomes, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies. * Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment Exclusion Criteria: * Patients who do not consent to participate
Where this trial is running
Chicago, Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Joshua B Wechsler, MD — Ann & Robert H Lurie Children's Hospital of Chicago
- Study coordinator: Angela Anthony
- Email: aanthony@luriechildrens.org
- Phone: 312-227-4559
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Eosinophilic Colitis, Eosinophilic Gastrointestinal Disease